Incidence and Mortality of Bladder Cancer and their Relationship with Development in Asia

  • Pakzad, Reza (Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences) ;
  • Mohammadian-Hafshejani, Abdollah (Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences) ;
  • Mohammadian, Mahdi (Isfahan University of Medical Sciences) ;
  • Pakzad, Iraj (Department of Microbiology, Medical School, Ilam University of Medical Sciences) ;
  • Safiri, Saeid (Department of Public Health, School of Nursing and Midwifery, Maragheh University of Medical Sciences) ;
  • Khazaei, Salman (Department of Epidemiology and Biostatistics, School of Public Health, Hamadan University of Medical Sciences) ;
  • Salehiniya, Hamid (Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences)
  • Published : 2015.11.04


Background: Over the past decade, bladder cancer was associated with a significant increase. Given the importance of the impact of socioeconomic status on the distribution of cancer incidence and mortality, and the need to information on these parameters for prevention planning, the aim of this study was to evaluate data for bladder cancer and their relationship with human development index (HDI) and its components in Asia in 2012. Materials and Methods: The study was conducted based on data from the world data of cancer and the World Bank (including the HDI and its components). The incidence and mortality rates were drawn for Asian countries. To analyze data, correlation tests between incidence and death rates, and HDI and its components were employed with a significance level of 0.05 using SPSS software. Results: A total incidence of 696,231 cases (68.7% in males and 31.3% in females, sex ratio of 2.19:1) and 524,465 deaths (67.0% in men and 32.9% in women, sex ratio was 2.03:1) were recorded in Asian countries in 2012. Correlation between HDI and standardized incidence rate was 0.241 overall (p=0.106), 0.236 in men (p=0.114) and -0.250 in women (p=0.094). Also between HDI and standardized mortality rate 0.025 (p=0.871) in men 0.118 (p=0.903) and in women 0.014 (p=0.927). Conclusions: Bladder cancer incidence is higher in developed countries, but the rate is declining, and in less developed and developing countries it is growing. There was no statistically significant correlation between the standardized incidence rate of bladder cancer and the HDI and its dimensions in Asia, except for the level of education.


Bladder cancer;incidence;mortality;HDI;Asia;development


  1. Adler NE, Ostrove JM (1999). Socioeconomic status and health: what we know and what we don’t. Ann New York Academy Sci, 896, 3-15.
  2. Ahmadi M, Ranjbaran H, Amiri MM, et al (2012). Epidemiologic and socioeconomic status of bladder cancer in mazandaran province, northern Iran. Asian Pac J Cancer Prev, 13, 5053-6.
  3. Akbari ME, Hosseini SJ, Rezaee A, et al (2008). Incidence of genitourinary cancers in the islamic republic of Iran: a survey in 2005. Asian Pac J Cancer Prev, 9, 549-52.
  4. Botteman M, Pashos C, Redaelli A, et al (2003). The health economics of bladder cancer. Pharmaco Economics, 21, 1315-30.
  5. Bray F, Jemal A, Grey N, et al (2012). Global cancer transitions according to the human development Index (2008-2030): a population-based study. Lancet Oncol, 13, 790-801.
  6. Burger M, Catto JWF, Dalbagni G, et al (2013). Epidemiology and risk factors of urothelial bladder cancer. European Urol, 63, 234-41.
  7. Consortium A (2004). Tobacco or health in the European Union: past, present and future, European Commission, Directorate General for Health and Consumer Protection.
  8. Creel P (2007). Bladder cancer: epidemiology, diagnosis, and treatment. Semin Oncol Nurs, 23, 3-S10.
  9. Delclos GL, Lerner SP (2008). Occupational risk factors. Scand J Urol Nephrol, 42, 58-63.
  10. Ezzati M, Lopez AD (2003a). Estimates of global mortality attributable to smoking in 2000. Lancet, 362, 847-52.
  11. Ezzati M, Lopez AD (2003b). Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tobacco Control, 12, 79-85.
  12. Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86.
  13. Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1. 0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [internet]. International Agency for Research on Cancer, Lyon. globocan. (accessed 10 October 2014).
  14. Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H (2015). Incidence and Mortality of Breast Cancer and their Relationship to Development in Asia. Asian Pac J Cancer Prev, 16, 6081-7.
  15. Hussain SK, Lenner P, Sundquist J, et al (2008). Influence of education level on cancer survival in Sweden. Ann Oncol, 19, 156-62.
  16. Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, et al (2014). Epidemiology and trend of cancers in the province of kerman: southeast of iran. Asian PacJ Cancer Prev, 16, 1409-13.
  17. Kirkali Z, Chan T, Manoharan M, et al (2005). Bladder cancer: Epidemiology, staging and grading, and diagnosis. Urol, 66, 4-34.
  18. Kogevinas M, Mannetje At, Cordier S, et al (2003). Occupation and bladder cancer among men in Western Europe. Cancer Causes Control, 14, 907-14.
  19. Lopez AD, Collishaw NE, Piha T (1994). A descriptive model of the cigarette epidemic in developed countries. Tobacco Control, 3, 242.
  20. Lyon F (2013). International agency for research on cancer; 2013.
  21. Mackay J, Eriksen M (2002). The tobacco atlas (World Health Organization, Geneva).
  22. Mackillop W, Zhang-Salomons J, Groome P, et al (1997). Socioeconomic status and cancer survival in Ontario. JClin Oncol, 15, 1680-9.
  23. Malats N, Real FX (2015). Epidemiology of bladder cancer. Hematol Oncol Clin North Am, 29, 177-89.
  24. Malik K (2013). Human development report 2013. the rise of the south: human progress in a diverse world. the rise of the south: human progress in a diverse world (March 15, 2013). UNDP-HDRO Human Development Reports.
  25. Messing EM, Young TB, Hunt VB, et al (1995). Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urol, 45, 387-97.
  26. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, et al (2007). Epidemiology of urinary bladder cancer: from tumor development to patient’s death. World Jo Urol, 25, 285-95.
  27. Ploeg M, Aben KK, Kiemeney LA (2009). The present and future burden of urinary bladder cancer in the world. World J Urol, 27, 289-93.
  28. Razi S, Rafiemanesh H, Ghoncheh M, et al (2014). Changing trends of types of skin cancer in Iran. Asian Pac J Cancer Prev, 16, 4955-8.
  29. Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al (2012). Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet, 380, 1840-50.
  30. Ward E, Jemal A, Cokkinides V, et al (2004). Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin, 54, 78-93.
  31. Yang Y, Wang J-J, Wang C-X, et al (2010). Awareness of tobaccorelated health hazards among adults in China. Biomed Environ Sci, 23, 437-44.
  32. Yavari P, Sadrolhefazi B, Mohagheghi M, et al (2009). A descriptive retrospective study of bladder cancer at a hospital in Iran (1973-2003). Asian Pac J Cancer Prev, 10, 681-4.

Cited by

  1. The Incidence and Mortality of Liver Cancer and its Relationship with Development in Asia vol.17, pp.4, 2016,
  2. Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern vol.6, pp.1, 2016,
  3. Correlation between municipal human development index and stroke mortality: a study of Brazilian capitals vol.11, pp.1, 2018,
  4. Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis vol.19, pp.1, 2019,